Benjamin Ruf

2.1k citations

29 papers · 869 indexed · 1 hit paper · h-index 14

Impact in

Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses

Papers in ⓘ

Immunology 16
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 4
- IL-33, ST2, and ILC Pathways 3
- Immunotherapy and Immune Responses 3
Oncology 14
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 3

Co-authors: Tim F. Greten (20 shared papers)Bernd Heinrich (9 shared papers)Firouzeh Korangy (9 shared papers)Xin Wei Wang (3 shared papers)Chi Ma (12 shared papers)Simon Wabitsch (10 shared papers)Laurence P. Diggs (6 shared papers)John C. McVey (7 shared papers)
Journals: iScience (2 papers)Molecular Therapy — Oncolytics (2 papers)Cancer Immunology Research (2 papers)Nature reviews. Cancer (1 paper)Journal of Hepatology (1 paper)
Partner nations: United States Germany South Korea

In The Last Decade

Benjamin Ruf

28 papers receiving 868 citations

Hit Papers

align trajectories log scale

Biomarkers for immunotherapy of hepatocellular carcinoma 2023 · 109 citations

Peers

Countries citing papers authored by Benjamin Ruf

Since Specialization

Citations

This map shows the geographic impact of Benjamin Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ruf more than expected).

Fields of papers citing papers by Benjamin Ruf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ruf. The network helps show where Benjamin Ruf may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Ruf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Ruf Line = papers co-authored together Benjamin Ruf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells Cellular and Molecular Immunology ·Benjamin Ruf, Bernd Heinrich, Tim F. Greten	2020	213
2	Biomarkers for immunotherapy of hepatocellular carcinoma Nature Reviews Clinical Oncology ·Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, Benjamin Ruf, Mark Yarchoan, Lichun Ma, Eytan Ruppin, Xin Wei Wang Hit paper breakdown →	2023	109
3	Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD Journal of Hepatology ·Simon Wabitsch, Justin McCallen, Olena Kamenyeva, Benjamin Ruf, John C. McVey, Juraj Kabát, Juliane S. Walz, Yaron Rotman, Kylynda C. Bauer, Amanda J. Craig, Marie Pouzolles, Ira Phadke, Vanessa V. Catania, Benjamin L. Green, Claude Fu, Laurence P. Diggs, Bernd Heinrich, Xin Wei Wang, Chi Ma, Tim F. Greten	2022	98
4	Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity Nature reviews. Cancer ·Benjamin Ruf, Tim F. Greten, Firouzeh Korangy	2023	69
5	Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice Gastroenterology ·Bernd Heinrich, Zachary J. Brown, Laurence P. Diggs, Mathias Vormehr, Chi Ma, Varun Subramanyam, Umberto Rosato, Benjamin Ruf, Juliane S. Walz, John C. McVey, Simon Wabitsch, Qiong Fu, Su Jong Yu, Qianfei Zhang, Chunwei W. Lai, Uğur Şahin, Tim F. Greten	2020	55
6	Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer Journal for ImmunoTherapy of Cancer ·Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M. Hernandez, Bradford J. Wood, Elliot Levy, Israa Juburi, Stephen M. Hewitt, David E. Kleiner, Seth M. Steinberg, William D. Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G. Duffy, Tim F. Greten	2023	46
7	Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response Cancer Immunology Research ·Benjamin Ruf, Vanessa V. Catania, Simon Wabitsch, Chi Ma, Laurence P. Diggs, Qianfei Zhang, Bernd Heinrich, Varun Subramanyam, Linda L. Cui, Marie Pouzolles, Christine N. Evans, Raj Chari, Shunsuke Sakai, Sangmi Oh, Clifton E. Barry, Daniel L. Barber, Tim F. Greten	2021	39
8	A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human Cells PLoS ONE ·Andrea Buchfellner, Larisa Yurlova, Stefan Nüske, A. Scholz, Jacqueline Bogner, Benjamin Ruf, Kourosh Zolghadr, Sophie E Drexler, G. Drexler, Stefanie Girst, Christoph Greubel, Judith Reindl, Christian Siebenwirth, Tina Romer, Anna A. Friedl, Ulrich Rothbauer	2016	33
9	Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma Molecular Therapy — Oncolytics ·Benjamin Ruf, Susanne Berchtold, Sascha Venturelli, Markus Burkard, Irina Smirnow, Tanja Prenzel, Stefan Henning, Ulrich M. Lauer	2015	26
10	Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting Journal of Telemedicine and Telecare ·Benjamin Ruf, Phillip Jenkinson, David Armour, Mhairi Fraser, Angus Watson	2019	25
11	Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice Cellular and Molecular Gastroenterology and Hepatology ·Simon Wabitsch, Mayank Tandon, Benjamin Ruf, Qianfei Zhang, Justin McCallen, John C. McVey, Chi Ma, Benjamin L. Green, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten	2021	24
12	NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice iScience ·John C. McVey, Benjamin L. Green, Benjamin Ruf, Justin McCallen, Simon Wabitsch, Varun Subramanyam, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten, Chi Ma	2022	18
13	Port‐a‐cath‐related Fusarium oxysporum infection in an HIV‐infected patient: treatment with liposomal amphotericin B Mycoses ·Julij Eljaschewitsch, J. Sandfort, Kathrin Tintelnot, I Horbach, Benjamin Ruf	1996	16
14	Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models iScience ·Simon Wabitsch, John C. McVey, Chi Ma, Benjamin Ruf, Olena Kamenyeva, Justin McCallen, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten	2020	15
15	Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers JHEP Reports ·Yuta Myojin, Justin McCallen, Chi Ma, Kylynda C. Bauer, Benjamin Ruf, Mohamed-Reda Benmebarek, Benjamin L. Green, Simon Wabitsch, John C. McVey, Claude Fu, Changqing Xie, Tim F. Greten	2023	12
16	Innate-like T cells in liver disease Trends in Immunology ·Albert Ying-Po Yang, Kilian Wistuba‐Hamprecht, Tim F. Greten, Benjamin Ruf	2024	12
17	Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”? Molecular Therapy — Oncolytics ·Benjamin Ruf, Ulrich M. Lauer	2015	12
18	Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma Frontiers in Immunology ·Bernd Heinrich, Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W. Lai, Amanda J. Craig, Jianyang Fu, Changqing Xie, Alexander Kroemer, Tim F. Greten, Firouzeh Korangy	2022	8
19	Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma Cancers ·Jihye L. Golino, Xin Wang, Jing Bian, Benjamin Ruf, Michael E. Kelly, Baktiar Karim, Maggie Cam, Changqing Xie	2023	8
20	Immunosuppressive CD29 ⁺ Treg accumulation in the liver in mice on checkpoint inhibitor therapy Gut ·Benjamin L. Green, Yuta Myojin, Chi Ma, Benjamin Ruf, Lichun Ma, Qianfei Zhang, Umberto Rosato, Jonathan Qi, Mahler Revsine, Simon Wabitsch, Kylynda C. Bauer, Mohamed-Reda Benmebarek, Justin McCallen, Amran Nur, Xin Wei Wang, Vivek Sehra, Revant Gupta, Manfred Claassen, Firouzeh Korangy, Tim F. Greten	2023	7

About Benjamin Ruf

Benjamin Ruf is a scholar working on Immunology, Oncology, Physiology, Pathology and Forensic Medicine and Cell Biology, having authored 29 papers that have together received 869 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (7 papers), T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), IL-33, ST2, and ILC Pathways (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Hepatology (146 citations), Immunology (298 citations), Oncology (343 citations), Cancer Research (146 citations) and Epidemiology (192 citations). Benjamin Ruf has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Tim F. Greten, Bernd Heinrich, Firouzeh Korangy, Xin Wei Wang, Chi Ma, Simon Wabitsch, Laurence P. Diggs, John C. McVey, Lichun Ma and Eytan Ruppin. Their work appears in journals such as iScience, Molecular Therapy — Oncolytics, Cancer Immunology Research, Nature reviews. Cancer and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact